Macrogen Europe GmbH, Swiss branch of Macrogen Europe B.V. (Amsterdam), provides fast, reliable Sanger and NGS sequencing. All sequencing labs are based in Amsterdam. We support research and clinical needs across Europe and Africa with advanced genomic and bioinformatics services.
Products, services, technology
Cooperation possibilities
We offer tailored sequencing and bioinformatics services, collaboration on genomic research projects, support for clinical diagnostics, and access to cutting-edge NGS and Sanger technologies. We partner with research institutions, biotech, and pharma to accelerate discoveries and innovation.
- https://www.macrogen-europe.com/
- +31 20 333 75 63
- Send an email
- Andrea Viglino
Some insights
We empower scientists, clinicians, and innovators with reliable genomic data, enabling breakthroughs in research, diagnostics, and personalized medicine. By advancing access to genetic insights, we contribute to better health, knowledge, and quality of life globally.
We are proud to support groundbreaking research and healthcare solutions through high-quality genomic services. Our commitment to accuracy, innovation, and customer care helps scientists and clinicians make impactful discoveries that improve lives worldwide.
Companies like Illumina, PacBio and TWIST or Agilent are role models in our industry for their continuous innovation, global impact, and commitment to advancing genomic technologies that enable research, diagnostics, and personalized medicine.
Our team combines deep expertise in genomics, bioinformatics, and customer support, ensuring high-quality data and tailored solutions. We aim to expand with professionals skilled in AI-driven analysis, clinical genomics, and regulatory compliance to meet future demands.
The Swiss biotech ecosystem can support us through networking opportunities, R&D partnerships, and increased visibility in clinical, pharma, biotech and academic sectors. Access to innovation hubs and collaborative projects would further enhance our presence and impact in Switzerland.
We would like to connect with academic researchers, clinical laboratories, biotech and pharma companies, as well as healthcare providers and innovation hubs interested in genomic solutions, research collaborations, and precision medicine.
